Background: The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted the
complex pathology of the virus, which extends beyond respiratory symptoms to include …

Recent studies on the pathogenesis and clinical spectrum of human disease following
infection with the new human pathogen, SARS-CoV-2, have identified the varied …

Abstract COVID-19, caused by SARS-CoV-2, emerged as the deadliest outbreak that has
now become a serious health issue to mankind. Activation of inflammatory signaling …

SARS-CoV-2, a novel coronavirus found in Wuhan (China) at the end of 2019, is the
etiological agent of the current pandemic that is a heterogeneous disease, named …

Since December 2019, the SARS-CoV-2 (COVID-19) pandemic has transfixed the medical
world. COVID-19 symptoms vary from mild to severe and underlying chronic conditions such …

One of the hallmarks of the SARS-CoV-2 infection has been the inflammatory process that
played a role in its pathogenesis, resulting in mortality within susceptible individuals. This …

Multisystem inflammatory syndrome in children (MIS-C) can occur in kids, who have severe
acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Clinically, characteristics of …

COVID‑19 patients with severe infection have been observed to have elevated auto‑
antibodies (AAs) against angiotensin II receptor type 1 (AT1R) and endothelin (ET) 1 …

Background As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including
more than 285,000 deaths have been reported to WHO. The risk of severe disease and …

Abstract During the SARS-CoV-2-associated infection (COVID-19), pandemic initial reports
suggested relative sparing of children inversely related to their age. Children and neonates …